These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32870371)
21. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
22. Associations between ocular melanoma and other primary cancers: an international population-based study. Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322 [TBL] [Abstract][Full Text] [Related]
29. Lymphoma of the ocular adnexa: A study of 353 cases. Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761 [TBL] [Abstract][Full Text] [Related]
30. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up. Tadmor T; Liphshitz I; Silverman B; Polliack A Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496 [TBL] [Abstract][Full Text] [Related]
32. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP; Clarke CA; Aroner S; Swetter SM J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559 [TBL] [Abstract][Full Text] [Related]
33. The treatment results in patients with lmphoma disease in the orbit. Furdová A; Marková A; Kapitánová K; Zahorjanová P Cesk Slov Oftalmol; 2018; 73(5-6):211-217. PubMed ID: 30541302 [TBL] [Abstract][Full Text] [Related]
34. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region. Ahmed AH; Foster CS; Shields CL JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986 [TBL] [Abstract][Full Text] [Related]
35. The association between malignant melanoma and noncutaneous malignancies. Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785 [TBL] [Abstract][Full Text] [Related]
36. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Auw-Haedrich C; Coupland SE; Kapp A; Schmitt-Gräff A; Buchen R; Witschel H Br J Ophthalmol; 2001 Jan; 85(1):63-9. PubMed ID: 11133714 [TBL] [Abstract][Full Text] [Related]
37. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis. Jiang S; Zhen H; Jiang H Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa. Nam SW; Woo KI; Kim YD Br J Ophthalmol; 2018 Apr; 102(4):502-508. PubMed ID: 28814410 [TBL] [Abstract][Full Text] [Related]
39. Histopathologic spectrum of paediatric eye and ocular adnexal tumours: A 10-year review from a referral centre in Nigeria. Suleiman DE; Iliyasu Y; Ahmed SA; Liman AA Niger J Clin Pract; 2020 May; 23(5):654-659. PubMed ID: 32367872 [TBL] [Abstract][Full Text] [Related]
40. [Characteristics of ocular adnexal non-Hodgkin lymphoma]. Yi WS; Xu XL; Xiang Q; Jiang HB Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):826-30. PubMed ID: 18812662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]